## Abstract ## Objective To assess the impact of cyclophosphamide (CYC) on the health‐related quality of life (HRQOL) of patients with scleroderma after 12 months of treatment. ## Methods One hundred fifty‐eight subjects participated in the Scleroderma Lung Study, with 79 each randomized to CYC
✦ LIBER ✦
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: Results from the scleroderma lung study
✍ Scribed by Dinesh Khanna; Philip J. Clements; Daniel E. Furst; Yun Chon; Robert Elashoff; Michael D. Roth; Mildred G. Sterz; Joannie Chung; John D. FitzGerald; James R. Seibold; John Varga; Arthur Theodore; Fredrick M. Wigley; Richard M. Silver; Virginia D. Steen; Maureen D. Mayes; M. Kari Connolly; Barri J. Fessler; Naomi F. Rothfield; Kamal Mubarak; Jerry Molitor; Donald P. Tashkin
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 120 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0004-3591
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Impact of oral cyclophosphamide on healt
✍
Dinesh Khanna; Xiaohong Yan; Donald P. Tashkin; Daniel E. Furst; Robert Elashoff
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
English
⚖ 92 KB
👁 1 views